Noida, UP -- (SBWIRE) -- 07/07/2014 -- The whole genome sequencing application unexpectedly allows personalized treatment for the patients. Indeed it has been considered as revolutionary tool serving researchers and clinicians. Genetic based mapping has taken off during past few years and whole genome sequencing has uncovered its potential to bring boost in precision medicine.
Market players have been exhaustively expanding their footprints in the whole genome sequencing market pertaining to personalized cancer treatment. A considerable amount of investment is being done in a way to follow personalized approach for disease prevention. Due to all this, cost for whole genome sequencing has declined and level of information has increased which therby would increase its affordability and accessability. This would ultimately create a much more profitable market in terms of personalized treatment with respect to genetic variants of the individual.
The report, “US Personalized Cancer Genome Sequencing Market Outlook 2018”, by RNCOS which is spread around 65 pages provides an in-depth research and rational analysis of the current status and expected Whole Genome Sequencing Market. Besides, it facilitates the current and potential of the Whole Genome Sequencing Market. The report prudently analyzed various factors such as cancer prevalence, incidence rates, and affordable states for WGS across United States. The report also covers the strengths and weaknesses of market players. A detailed study of regulatory insights has been covered in the report. Further, the report also illustrates the market restraints that impact the potential of Whole Genome Sequencing market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM672.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.